285 lines (284 with data), 10.1 kB
T1 Age 18 29 18-year-old
T2 Personal_background 30 33 Han
T3 Sex 34 40 female
T4 Clinical_event 41 49 admitted
E1 Clinical_event:T4
T5 Nonbiological_location 53 90 Peking Union Medical College Hospital
R1 MODIFY Arg1:T5 Arg2:E1
T6 Disease_disorder 126 135 pneumonia
E2 Disease_disorder:T6
T7 Disease_disorder 98 112 adrenal crisis
E3 Disease_disorder:T7
R2 CAUSE Arg1:E2 Arg2:E3
T8 Disease_disorder 177 187 infections
E4 Disease_disorder:T8
T9 Biological_structure 165 176 respiratory
T10 Detailed_description 155 164 recurrent
R3 MODIFY Arg1:T9 Arg2:E4
R4 MODIFY Arg1:T10 Arg2:E4
T11 Date 194 199 age 5
E5 Date:T11
T12 Medication 259 271 vaccinations
E6 Medication:T12
T13 Detailed_description 226 234 multiple
R5 MODIFY Arg1:T13 Arg2:E6
T14 Detailed_description 235 252 hepatitis B virus
R6 MODIFY Arg1:T14 Arg2:E6
T15 Detailed_description 254 257 HBV
R7 IDENTICAL Arg1:T15 Arg2:T14
T16 Diagnostic_procedure 287 295 cortisol
E7 Diagnostic_procedure:T16
T17 Diagnostic_procedure 300 304 ACTH
E8 Diagnostic_procedure:T17
T18 Detailed_description 281 286 serum
R8 MODIFY Arg1:T18 Arg2:E7
R9 MODIFY Arg1:T18 Arg2:E8
T19 Lab_value 273 280 Reduced
R10 MODIFY Arg1:T19 Arg2:E7
R11 MODIFY Arg1:T19 Arg2:E8
T20 Date 331 333 16
E9 Date:T20
#1 AnnotatorNotes E9 Age 16
T21 History 155 199 recurrent respiratory infections since age 5
T22 History 205 271 failed to respond to multiple hepatitis B virus (HBV) vaccinations
T23 History 273 333 Reduced serum cortisol and ACTH levels were discovered at 16
T24 Medication 339 365 glucocorticoid replacement
E10 Medication:T24
T25 History 339 365 glucocorticoid replacement
T26 Sign_symptom 394 403 hair loss
E11 Sign_symptom:T26
T27 Date 417 422 age 4
E12 Date:T27
T28 History 394 422 hair loss started from age 4
T29 Sign_symptom 428 462 absence of pubic and axillary hair
E13 Sign_symptom:T29
T30 Other_event 481 516 development of regular menstruation
E14 Other_event:T30
#2 AnnotatorNotes E14 Not a date, but relevant to observations in a temporal way
T31 History 428 516 absence of pubic and axillary hair was noticed after development of regular menstruation
T32 Disease_disorder 539 557 nephrotic syndrome
E15 Disease_disorder:T32
T33 History 539 557 nephrotic syndrome
T34 Disease_disorder 585 611 minimal change nephropathy
E16 Disease_disorder:T34
T35 Diagnostic_procedure 621 627 biopsy
E17 Diagnostic_procedure:T35
T36 Biological_structure 615 620 renal
R12 MODIFY Arg1:T36 Arg2:E17
T37 History 585 627 minimal change nephropathy by renal biopsy
T38 Diagnostic_procedure 629 649 Physical examination
E18 Diagnostic_procedure:T38
T39 Disease_disorder 672 688 alopecia totalis
E19 Disease_disorder:T39
T40 Disease_disorder 695 706 candidiasis
E20 Disease_disorder:T40
T41 Biological_structure 690 694 oral
R13 MODIFY Arg1:T41 Arg2:E20
T42 Disease_disorder 708 720 hypohidrosis
E21 Disease_disorder:T42
T43 Sign_symptom 726 739 trachyonychia
E22 Sign_symptom:T43
T44 Family_history 798 808 only child
T45 Sign_symptom 758 771 abnormalities
E23 Sign_symptom:T45
A1 POLARITY E23 NEG
T46 Biological_structure 751 757 dental
T47 Biological_structure 741 747 Facial
R14 MODIFY Arg1:T46 Arg2:E23
R15 MODIFY Arg1:T47 Arg2:E23
T48 Family_history 824 920 Symptom and signs of the above disorders were not identified among her nonconsanguineous parents
T49 Diagnostic_procedure 930 947 immunologic tests
E24 Diagnostic_procedure:T49
T50 Sign_symptom 968 992 panhypogammaglobulinemia
E25 Sign_symptom:T50
T51 Diagnostic_procedure 1005 1016 cell counts
E26 Diagnostic_procedure:T51
R16 SUB_PROCEDURE Arg1:E26 Arg2:E24
T52 Lab_value 997 1004 reduced
R17 MODIFY Arg1:T52 Arg2:E26
T53 Diagnostic_procedure 1020 1027 B cells
E27 Diagnostic_procedure:T53
T54 Diagnostic_procedure 1029 1036 T cells
E28 Diagnostic_procedure:T54
T55 Diagnostic_procedure 1042 1067 natural killer (NK) cells
E29 Diagnostic_procedure:T55
R18 SUB_PROCEDURE Arg1:E27 Arg2:E26
R19 SUB_PROCEDURE Arg1:E28 Arg2:E26
R20 SUB_PROCEDURE Arg1:E29 Arg2:E26
T56 Diagnostic_procedure 1089 1102 CD4/CD8 ratio
E30 Diagnostic_procedure:T56
T57 Diagnostic_procedure 1115 1132 expression levels
E31 Diagnostic_procedure:T57
T58 Diagnostic_procedure 1144 1169 T-cell activation markers
E32 Diagnostic_procedure:T58
R21 SUB_PROCEDURE Arg1:E32 Arg2:E31
T59 Lab_value 1178 1190 normal range
R22 MODIFY Arg1:T59 Arg2:E32
T60 Diagnostic_procedure 1209 1242 proportion of CD8+/HLA-DR+ subset
E33 Diagnostic_procedure:T60
T61 Lab_value 1199 1208 increased
R23 MODIFY Arg1:T61 Arg2:E33
R24 SUB_PROCEDURE Arg1:E33 Arg2:E31
T62 Diagnostic_procedure 1244 1266 Antinuclear antibodies
E34 Diagnostic_procedure:T62
T63 Diagnostic_procedure 1268 1271 ANA
E35 Diagnostic_procedure:T63
T64 Diagnostic_procedure 1277 1314 antineutrophil cytoplasmic antibodies
E36 Diagnostic_procedure:T64
T65 Diagnostic_procedure 1316 1320 ANCA
E37 Diagnostic_procedure:T65
R25 IDENTICAL Arg1:E37 Arg2:E36
R26 IDENTICAL Arg1:E35 Arg2:E34
T66 Lab_value 1327 1335 negative
R27 MODIFY Arg1:T66 Arg2:E36
R28 MODIFY Arg1:T66 Arg2:E34
T67 Medication 1350 1376 hydrocortisone replacement
E38 Medication:T67
A2 POLARITY E38 NEG
T68 Diagnostic_procedure 1410 1418 cortisol
E39 Diagnostic_procedure:T68
T69 Detailed_description 1404 1409 serum
R29 MODIFY Arg1:T69 Arg2:E39
T70 Time 1396 1403 8:00 am
E40 Time:T70
R30 MODIFY Arg1:E40 Arg2:E39
T71 Lab_value 1435 1445 0.93 μg/dL
R31 MODIFY Arg1:T71 Arg2:E39
T72 Diagnostic_procedure 1452 1456 ACTH
E41 Diagnostic_procedure:T72
T73 Lab_value 1457 1468 <5.00 pg/mL
R32 MODIFY Arg1:T73 Arg2:E41
T74 Diagnostic_procedure 1492 1519 anterior pituitary hormones
E42 Diagnostic_procedure:T74
T75 Detailed_description 1470 1475 Serum
R33 MODIFY Arg1:T75 Arg2:E42
T76 Diagnostic_procedure 1548 1558 osmolality
E43 Diagnostic_procedure:T76
T77 Detailed_description 1532 1537 serum
T78 Detailed_description 1542 1547 urine
R34 MODIFY Arg1:T78 Arg2:E43
R35 MODIFY Arg1:T77 Arg2:E43
T79 Lab_value 1564 1586 within reference range
R36 MODIFY Arg1:T79 Arg2:E42
R37 MODIFY Arg1:T79 Arg2:E43
T80 Diagnostic_procedure 1593 1616 antiperoxidase antibody
E44 Diagnostic_procedure:T80
T81 Diagnostic_procedure 1621 1647 antithyroglobulin antibody
E45 Diagnostic_procedure:T81
T82 Lab_value 1653 1661 negative
R38 MODIFY Arg1:T82 Arg2:E45
R39 MODIFY Arg1:T82 Arg2:E44
T83 Diagnostic_procedure 1680 1721 antiprotein tyrosine phosphatase antibody
E46 Diagnostic_procedure:T83
T84 Lab_value 1671 1679 positive
R40 MODIFY Arg1:T84 Arg2:E46
T85 Diagnostic_procedure 1728 1749 fasting blood glucose
E47 Diagnostic_procedure:T85
T86 Lab_value 1753 1763 5.9 mmol/L
R41 MODIFY Arg1:T86 Arg2:E47
T87 Diagnostic_procedure 1765 1791 Magnetic resonance imaging
E48 Diagnostic_procedure:T87
T88 Detailed_description 1797 1805 contrast
R42 MODIFY Arg1:T88 Arg2:E48
T89 Diagnostic_procedure 1825 1834 pituitary
E49 Diagnostic_procedure:T89
T90 Lab_value 1818 1824 normal
R43 MODIFY Arg1:T90 Arg2:E49
T91 Disease_disorder 1859 1863 CVID
E50 Disease_disorder:T91
#3 AnnotatorNotes E50 Common variable immune deficiency
T92 Disease_disorder 1865 1889 isolated ACTH deficiency
E51 Disease_disorder:T92
#4 AnnotatorNotes E51 isolated adrenocorticotropic hormone deficiency
T93 Disease_disorder 1895 1915 ectodermal dysplasia
E52 Disease_disorder:T93
T94 Sign_symptom 1929 1934 fever
E53 Sign_symptom:T94
T95 Sign_symptom 1936 1941 cough
E54 Sign_symptom:T95
T96 Sign_symptom 1947 1955 vomiting
E55 Sign_symptom:T96
A3 POLARITY E55 NEG
A4 POLARITY E54 NEG
A5 POLARITY E53 NEG
T97 Medication 1969 1980 antibiotics
E56 Medication:T97
T98 Medication 1997 2011 hydrocortisone
E57 Medication:T98
T99 Detailed_description 1985 1996 stress-dose
R44 MODIFY Arg1:T99 Arg2:E57
T100 Medication 2023 2049 Intravenous immunoglobulin
E58 Medication:T100
T101 Medication 2051 2055 IVIG
E59 Medication:T101
R45 IDENTICAL Arg1:E59 Arg2:E58
A6 POLARITY E58 NEG
T102 Clinical_event 2109 2118 follow-up
E60 Clinical_event:T102
T103 Date 2119 2131 1 year after
E61 Date:T103
T104 Disease_disorder 2163 2172 infection
E62 Disease_disorder:T104
A7 POLARITY E62 NEG
T105 Duration 2180 2204 during the previous year
E63 Duration:T105
T106 Clinical_event 2212 2218 stayed
E64 Clinical_event:T106
T107 Nonbiological_location 2222 2226 home
R46 MODIFY Arg1:T107 Arg2:E64
T108 Activity 2239 2257 outdoor activities
E65 Activity:T108
A8 POLARITY E65 NEG
T109 Medication 2263 2289 glucocorticoid replacement
E66 Medication:T109
A9 POLARITY E66 NEG
T110 Date 2304 2318 4 months after
E67 Date:T110
T111 Medication 2356 2384 traditional Chinese medicine
E68 Medication:T111
T112 Diagnostic_procedure 2397 2420 Lymphocyte subsets test
E69 Diagnostic_procedure:T112
T113 Diagnostic_procedure 2474 2481 B cells
E70 Diagnostic_procedure:T113
T114 Diagnostic_procedure 2486 2493 T cells
E71 Diagnostic_procedure:T114
T115 Lab_value 2454 2463 increased
R47 MODIFY Arg1:T115 Arg2:E70
R48 MODIFY Arg1:T115 Arg2:E71
R49 SUB_PROCEDURE Arg1:E70 Arg2:E69
R50 SUB_PROCEDURE Arg1:E71 Arg2:E69
T116 Diagnostic_procedure 2501 2514 NK cell count
E72 Diagnostic_procedure:T116
T117 Lab_value 2524 2542 below normal limit
R51 MODIFY Arg1:T117 Arg2:E72
T118 Diagnostic_procedure 2578 2603 flow cytometric procedure
E73 Diagnostic_procedure:T118
* OVERLAP E1 E3
R52 AFTER Arg1:E3 Arg2:E4
R54 BEFORE Arg1:E6 Arg2:E7
* OVERLAP E7 E8 E9 E10
* OVERLAP E4 E5
R53 BEFORE Arg1:E5 Arg2:E6
R55 AFTER Arg1:E10 Arg2:E11
* OVERLAP E11 E12
R56 BEFORE Arg1:E12 Arg2:E13
R57 AFTER Arg1:E13 Arg2:E14
R58 BEFORE Arg1:E14 Arg2:E15
* OVERLAP E15 E16 E17
R59 BEFORE Arg1:E17 Arg2:E18
* OVERLAP E18 E19 E20 E21 E22 E23 E24 E25 E30 E31 E34 E36
R60 BEFORE Arg1:E36 Arg2:E38
* OVERLAP E38 E40 E39 E41 E42 E43 E44 E45 E46 E47 E48 E49
R61 BEFORE Arg1:E49 Arg2:E50
* OVERLAP E50 E51 E52
R62 BEFORE Arg1:E52 Arg2:E53
* OVERLAP E53 E54 E55 E56 E57
R63 BEFORE Arg1:E57 Arg2:E58
R64 BEFORE Arg1:E58 Arg2:E60
* OVERLAP E60 E61 E62
R65 AFTER Arg1:E62 Arg2:E63
* OVERLAP E63 E64 E65
R66 BEFORE Arg1:E65 Arg2:E66
* OVERLAP E66 E67 E68
R67 BEFORE Arg1:E68 Arg2:E69
* OVERLAP E69 E72 E73